fmt for children with recurrent clostridium difficile infection
DESCRIPTION
FMT for Children with Recurrent Clostridium difficile Infection. George Hylands Russell, MD, MSc 2014 James W. Freston Conference Chicago, Illinois August 17, 2015. I have no financial relationships with any commercial entity to disclose. Plan. A special population - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: FMT for Children with Recurrent Clostridium difficile Infection](https://reader036.vdocuments.net/reader036/viewer/2022062519/568151bd550346895dbfeeff/html5/thumbnails/1.jpg)
FMT for Children with Recurrent Clostridium difficile Infection
George Hylands Russell, MD, MSc2014 James W. Freston Conference
Chicago, IllinoisAugust 17, 2015
![Page 2: FMT for Children with Recurrent Clostridium difficile Infection](https://reader036.vdocuments.net/reader036/viewer/2022062519/568151bd550346895dbfeeff/html5/thumbnails/2.jpg)
I have no financial relationships with any commercial entity to disclose
![Page 3: FMT for Children with Recurrent Clostridium difficile Infection](https://reader036.vdocuments.net/reader036/viewer/2022062519/568151bd550346895dbfeeff/html5/thumbnails/3.jpg)
Plan
• A special population• A quick look at the literature• NASPGHAN next steps
![Page 4: FMT for Children with Recurrent Clostridium difficile Infection](https://reader036.vdocuments.net/reader036/viewer/2022062519/568151bd550346895dbfeeff/html5/thumbnails/4.jpg)
How is Pediatric RCDI different?
• C. diff is constitutive flora until after 6 months of age, 10 % carriage rate at 1 year
• 10 fold rise in incidence from 1991-2009 • Refractory C. diff is rare. Recurrence risk is about 22-
30% as in adults.• Community acquired C. diff is more common than in
adults• 23-43% lack antimicrobial exposure history• Up to 38% of previously healthy children with RCDI
have NAP1/B1/027 serotypeBenson L, et al. Infect Control Hosp Epidemiol. 2007;28(11):1233–1235.Khanna S BL, et al. Clin Infect Dis. 2013;56(10):1401-1406.Janqi S, et al. JPGN. 2010; 51:2-7.
![Page 5: FMT for Children with Recurrent Clostridium difficile Infection](https://reader036.vdocuments.net/reader036/viewer/2022062519/568151bd550346895dbfeeff/html5/thumbnails/5.jpg)
A special population
• A vulnerable population• Potential life-long ramifications?• Long-term safety is a longer term concern• Registry and follow up data on outcomes and
health status particularly interesting and important
![Page 6: FMT for Children with Recurrent Clostridium difficile Infection](https://reader036.vdocuments.net/reader036/viewer/2022062519/568151bd550346895dbfeeff/html5/thumbnails/6.jpg)
• Pediatric index case• 24 month old girl with community acquired
RCDI (6 recurrences)• Nasogastric tube delivery• Healthy screened paternal donor • Safe and well in 24 hours now with 5 years f/u
Russell GH, et al. Pediatrics. 2010; 126: e-239-242.
![Page 7: FMT for Children with Recurrent Clostridium difficile Infection](https://reader036.vdocuments.net/reader036/viewer/2022062519/568151bd550346895dbfeeff/html5/thumbnails/7.jpg)
• 16 month old with community acquired RCDI (6 recurrences) that began at 11 mos of age after Azithromycin for bronchitis
• 1st pediatric case documented with colonoscopic delivery
• Testing and delivery by FMT Working Group Guidelines (Baaken J, et al. Clin Gastro Hep. 2011; 9:1044-1049)
• Improvement in 24 hours. Safe and well in F/UKahn S, et al. AmJGastro. 2012; 107: 1930-1.
![Page 8: FMT for Children with Recurrent Clostridium difficile Infection](https://reader036.vdocuments.net/reader036/viewer/2022062519/568151bd550346895dbfeeff/html5/thumbnails/8.jpg)
• Largest pediatric case series• Patients who received FMT for RCDI between
2009-2013 at MGH for Children• 2 nasogastric tube delivery/ 8 by colonoscopic
delivery• 90% success rate• Safe in patients with and without
Inflammatory Bowel DiseaseRussell GH, et al. JPGN. 2014; 58(5): 588-592.
![Page 9: FMT for Children with Recurrent Clostridium difficile Infection](https://reader036.vdocuments.net/reader036/viewer/2022062519/568151bd550346895dbfeeff/html5/thumbnails/9.jpg)
Russell GH, et al. JPGN. 2014; 58(5): 588-592.
![Page 10: FMT for Children with Recurrent Clostridium difficile Infection](https://reader036.vdocuments.net/reader036/viewer/2022062519/568151bd550346895dbfeeff/html5/thumbnails/10.jpg)
Russell GH, et al. JPGN. 2014; 58(5): 588-592.
![Page 11: FMT for Children with Recurrent Clostridium difficile Infection](https://reader036.vdocuments.net/reader036/viewer/2022062519/568151bd550346895dbfeeff/html5/thumbnails/11.jpg)
Russell GH, et al. JPGN. 2014; 58(5): 588-592.
• Counted as a failure• Redeveloped CDI after re-admission
![Page 12: FMT for Children with Recurrent Clostridium difficile Infection](https://reader036.vdocuments.net/reader036/viewer/2022062519/568151bd550346895dbfeeff/html5/thumbnails/12.jpg)
Russell GH, et al. JPGN. 2014; 58(5): 588-592.
• Admitted for severe acute colitis• RCDI vs UC• 100% better for 5 days then resumed severe bloody diarrhea• Never redeveloped CDI• Potential fulminant UC flare secondary to FMT?
![Page 13: FMT for Children with Recurrent Clostridium difficile Infection](https://reader036.vdocuments.net/reader036/viewer/2022062519/568151bd550346895dbfeeff/html5/thumbnails/13.jpg)
Russell GH, et al. JPGN. 2014; 58(5): 588-592.
![Page 14: FMT for Children with Recurrent Clostridium difficile Infection](https://reader036.vdocuments.net/reader036/viewer/2022062519/568151bd550346895dbfeeff/html5/thumbnails/14.jpg)
Russell GH, et al. JPGN. 2014; 58(5): 588-592.
• Role of colonization and the sensitivity of the PCR test• No change in symptoms occurred (even when RCDI was cleared)
when RCDI was not clearly causative
![Page 15: FMT for Children with Recurrent Clostridium difficile Infection](https://reader036.vdocuments.net/reader036/viewer/2022062519/568151bd550346895dbfeeff/html5/thumbnails/15.jpg)
Columbia experience – Ahead of Print
• 6 patients with at least 2 RCDI– 4 of whom had comorbidities: IBD, Hirschsprung disease,
G-tube dependence• Cure rate of 100%• All screened parent donors – all received PEG 17
grams BID x 2 days.• All by colonoscopy following general FMT Working
Group guidelines (Baaken J, et al. Clin Gastro Hep. 2011; 9:1044-1049)
• Potential adverse effect in patient with IBD (developed appendicitis after FMT)
Pierog A, et al. JPGN. 2014; 10.1097/INF.0000000000000419.
![Page 16: FMT for Children with Recurrent Clostridium difficile Infection](https://reader036.vdocuments.net/reader036/viewer/2022062519/568151bd550346895dbfeeff/html5/thumbnails/16.jpg)
• NASPGHAN has sponsored the FMT Special Interest Group
• Standardize pediatric FMT protocols– Standardize recipient/donor consents– Standardize minimal donor testing– Educate and communicate with the Pediatric GI
community– Liaison with adult groups and other professional
organizations